Aimei Health Technology Co., Ltd.
For the period ended Sep 30, 2025. Filed Nov 18, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 18, 2025
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2025-06-30; filed 2025-08-13.
0001493152-25-011904
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2025-09-30; filed 2025-11-18.
0001493152-25-024062
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 25 previous paragraphs and 26 current paragraphs.
23 unchanged; 2 reworded; 1 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
As previously disclosed, on November 6, 2025, the Company convened an extraordinary general meeting of shareholders, at which Aimei Health’s shareholders approved the proposed business combination with United Hydrogen. As of the date of this Quarterly Report, the Company expects to close the business combination in early 2026, subject to various conditions, including shareholder approvals and regulatory clearances.
Reworded paragraphs (2)
Previous wording
For the six months ended June 30, 2025, we had net income of $609,632, which consisted of interest income earned on assets held in the Trust Account of $1,064,650, offset by formation and operational costs of $455,018. For the six months ended June 30, 2024, we had net income of $1,364,592, which consisted of dividend income earned on investments held in the Trust Account of $1,827,338, offset by formation and operational costs of $462,746. For the three months ended June 30, 2025, we had net income of $424,970, which consisted of interest income earned on assets held in the Trust Account of $466,574, offset by formation and operational costs of $41,604. For the three months ended June 30, 2024, we had net income of $609,092, which consisted of dividend income earned on investments held in the Trust Account of $918,206, offset by formation and operational costs of $309,114.
Current wording
For the nine months ended September 30, 2025, we had net income of $961,651, which consisted of interest income earned on cash held in the Trust Account of $1,546,821, offset by formation and operational costs of $585,170. For the nine months ended September 30, 2024, we had net income of $2,108,102, which consisted of dividend income earned on cash held in the Trust Account of $2,770,867, offset by formation and operational costs of $662,765. For the three months ended September 30, 2025, we had net income of $352,019, which consisted of interest income earned on cash held in the Trust Account of $482,171, offset by formation and operational costs of $130,152. For the three months ended September 30, 2024, we had net income of $743,510, which consisted of dividend income earned on cash held in the Trust Account of $943,529, offset by formation and operational costs of $200,019.
Previous wording
As of June 30, 2025, we had $2,138 in our operating bank account, $44,511,399 in our Trust Account, and working capital deficit of approximately $2,169,328.
Current wording
As of September 30, 2025, we had $2,979 in our operating bank account, $45,443,570 in our Trust Account, and working capital deficit of approximately $2,749,480.